EMA Authorised: Zubsolv (buprenorphine hydrochloride;naloxone hydrochloride dihydrate) — Accord Healthcare S.L.U.

View source ↗

Summary

The European Medicines Agency authorized Zubsolv, a fixed-dose buprenorphine/naloxone product, for opioid-related disorders; the marketing authorization holder …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• ZUBSOLV (Buprenorphine hydrochloride and naloxone hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Opioid-Related Disorders. MAH: Accord Healthcare S.L.U.. Decision date: 08/12/2025